Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children

Pediatric Blood and Cancer

Volumn 53, Issue 7, 2009, Pages 1315-1317

  Kjaersgaard, Mimi ^a   Edslev, Pernille Wendtland ^a   Hasle, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anti D; Bleeding score; Childhood; ITP; Subcutaneous

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE; RHESUS D ANTIBODY; ALLOANTIBODY; RHO(D) ANTIBODY;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG TOLERABILITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; INJECTION SITE PAIN; MALE; ONSET AGE; PRIORITY JOURNAL; RETICULOCYTE COUNT; SCHOOL CHILD; THROMBOCYTE COUNT; TREATMENT RESPONSE; BLEEDING; BLOOD; FEVER; IMMUNOTHERAPY; MULTICENTER STUDY; PAIN; PRESCHOOL CHILD; PROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHILLS; FEMALE; FEVER; HEMOGLOBINS; HEMORRHAGE; HUMANS; IMMUNOTHERAPY; INFANT; INJECTIONS, SUBCUTANEOUS; ISOANTIBODIES; MALE; PAIN; PLATELET COUNT; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 70449719260     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22248     Document Type: Article

References (20)

1. 0(D)). Blut 1984;49:29-35.
2. Blanchette VS, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-707.
3. Scaradavou A, Woo B, Woloski BM, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 1997;89:2689-2700.
4. Freiberg A, Mauger D. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Semin Hematol 1998;35:23-27.
5. Ochs HD, Gupta S, Kiessling P, et al. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Invest 2006;26:265-273.
6. Meyer O, Kiesewetter H, Hermsen M, et al. Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia. Eur J Haematol 2004;73:71-72.
7. Meyer O, Kiesewetter H, Hermsen M, et al. Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia. Pediatr Blood Cancer 2006;47:721-722.
8. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002;141:683-688.
9. Monteleone PM, Vander Heyden MA, Steele DA, et al. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: A pilot study. Haematologica 2000;85:887-888.
10. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child 1994;71:251-253.
11. Butros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: A retrospective analysis. J Pediatr Hematol Oncol 2003;25:660-664.
12. Smith GN, Griffiths B, Mollison D, et al. Uptake of IgG after intramuscular and subcutaneous injection. Lancet 1972;1:1208-1212.
13. Bonilla FA. Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes. Immunol Allergy Clin North Am 2008;28:803-819, ix.
14. Kjaersgaard M, Aslam R, Kim M, et al. Epitope specificity and isotype of monoclonal anti-D antibodies dictate their ability to inhibit phagocytosis of opsonized platelets. Blood 2007;110:1359-1361.
15. Semple JW, Allen D, Rutherford M, et al. Anti-D (WinRho) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production.Am J Hematol 2002;69:225-227.
16. Siragam V, Crow AR, Brinc D, et al. Intravenous immunoglobulin ameliorates ITP via activating Fcg receptors on dendritic cells. Nat Med 2006;12:688-692.
17. Kjaersgaard M, Hasle H.Areviewof anti-D treatment of childhood idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2006;47:717-720.
18. Gardulf A, Andersen V, Bjorkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs. Lancet 1995;345:365-369.
19. Tarantino MD, Madden RM, Fennewald DL, et al. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 1999;134:21-26.
20. Tarantino MD, Young G, Bertolone SJ, et al. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr 2006;148:489-494.